Unbiased AI-powered news
A large sunspot region on the far side of the sun was imaged by the European Space Agency's Solar Orbiter spacecraft. The region is expected to rotate into view from Earth around May 22 and may produce auroras.
ForbesA large sunspot region on the far side of the sun was imaged by the European Space Agency's Solar Orbiter spacecraft on May 18. The spacecraft captured X-ray images showing the region, which has already produced solar flares. com. No additional flares have been recorded since those dates.
Sunspots are regions of intense magnetic fields that can generate solar flares and coronal mass ejections. Coronal mass ejections are clouds of charged particles that can interact with Earth's magnetic field and produce geomagnetic storms. Geomagnetic storms can cause displays of the northern and southern lights.
The sunspot region is expected to face Earth starting around May 22 and may remain active during that period. The same sunspot region was also observed in images taken by NASA's Perseverance rover on Mars. The rover uses its Mastcam-Z camera to photograph the sun while measuring atmospheric dust levels.
The sun is moving past the peak of its roughly 11-year solar cycle. Scientists at NOAA and NASA estimate the solar maximum occurred in October 2024, though activity can continue in the tail of the peak. In June 2025 it captured the first clear images of the sun's south pole from an orbit below the solar equator.
Single source — no framing comparison available.
hothardware.comSpectral analysis of 2024 and 2025 observations revealed helium escaping from the planet 48 light-years away. The results, published in Science, confirm LHS 1140 b as the first known rocky world in a habitable zone that retains an atmosphere.
680news.comA second person has died in a Legionnaires’ disease outbreak on Manhattan’s Upper East Side that has sickened at least 72 people. City officials reported a sustained drop in new cases after directing remediation of cooling towers in more than 75 buildings.
sbs.com.auThe Sydney Morning Herald reported that only 25 percent of new medicines launched worldwide in the last decade have been subsidized under Australia's Pharmaceutical Benefits Scheme. Eighteen innovative treatments for cancer, mental illness and rare diseases remain unavailable.